| Primary |
| Acute Myocardial Infarction |
100.0% |
|
| Coronary Artery Stenosis |
25.0% |
| Drug Ineffective |
25.0% |
| Left Ventricular Dysfunction |
25.0% |
| Staphylococcal Sepsis |
25.0% |
|
| Secondary |
| Acute Myocardial Infarction |
96.6% |
| Myocardial Infarction |
1.2% |
| Drug Use For Unknown Indication |
0.7% |
| Angioplasty |
0.3% |
| Percutaneous Coronary Intervention |
0.3% |
| Procedural Complication |
0.3% |
| Coronary Arterial Stent Insertion |
0.1% |
| Diuretic Therapy |
0.1% |
| Hypertension |
0.1% |
| Pneumonia |
0.1% |
|
| Coronary Artery Stenosis |
19.4% |
| Ventricular Fibrillation |
16.8% |
| Cardiac Failure |
8.7% |
| Coronary Artery Disease |
7.7% |
| Myocardial Ischaemia |
6.1% |
| Ischaemia |
5.1% |
| Myocardial Infarction |
5.1% |
| Ventricular Tachycardia |
4.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Thrombocytopenia |
3.1% |
| Injection Site Haemorrhage |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Left Ventricular Failure |
2.0% |
| Mallory-weiss Syndrome |
2.0% |
| Pneumonia |
2.0% |
| Ventricular Arrhythmia |
2.0% |
| Ventricular Hypokinesia |
2.0% |
| Cardiogenic Shock |
1.5% |
| Intracardiac Thrombus |
1.5% |
| Myalgia |
1.5% |
|
| Concomitant |
| Mycobacterium Avium Complex Infection |
64.3% |
| Thrombosis Prophylaxis |
14.3% |
| Percutaneous Coronary Intervention |
10.7% |
| Acute Myocardial Infarction |
3.6% |
| Antiplatelet Therapy |
3.6% |
| Nuclear Magnetic Resonance Imaging |
3.6% |
|
| Thrombosis In Device |
63.6% |
| Intraventricular Haemorrhage |
9.1% |
| Presyncope |
9.1% |
| Renal Failure Acute |
9.1% |
| Vascular Access Complication |
9.1% |
|
| Interacting |
| Acute Myocardial Infarction |
100.0% |
|
| Subcutaneous Haematoma |
100.0% |
|
